When Roche previewed the Axelios technology in February, a Jefferies analyst called the next-generation sequencing platform the “greatest credible competitive threat in years.” ...
Roche launches AXELIOS 1, a transformative next-generation sequencing platform: Basel Tuesday, June 30, 2026, 10:00 Hrs [IST] Roche, a healthcare company, announced the launch of ...
Next-generation sequencing (NGS) technologies have revolutionised phylogenetic analysis by enabling the acquisition of genome-scale data. Phylogenetic inference reconstructs evolutionary relationships ...
The US Food and Drug Administration (FDA) has released draft guidance on how sponsors can utilize next-generation sequencing (NGS) methods in nonclinical studies to assess the safety risks associated ...
Ultima Genomics, Inc., a developer of ultra-high-throughput sequencing systems, continues its mission to enable sequencing at scale with the unveiling of the UG200 Series and next generation Solaris 2 ...
Natera NTRA announced the commercial launch of Zenith genomics, a next-generation whole genome sequencing assay designed to improve the detection and diagnosis of rare genetic diseases. The core ...
Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Next Generation Sequencing Services Market size & share revenue was valued ...
Roche may have failed to buy out Illumina back in 2012, but now it’s trying to take up some of the gene sequencing specialist ...
Hosted on MSN
Living DNA vs. Whole Genome Sequencing: Choosing the Right DNA Test for Your 2026 Tech Journey
As 2026 brings AI-driven genealogy tools to the mainstream, the decision between a Living DNA genotyping kit and full whole-genome sequencing is no longer just about ancestry percentages—it's about ...
Medical Device Network on MSN
Roche launches Axelios 1 sequencing platform
The launch was supported by collaborations with institutions such as the Hartwig Medical Foundation and Broad Clinical Labs.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results